LIGUORI, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 239
AS - Asia 158
NA - Nord America 84
SA - Sud America 22
AF - Africa 1
Totale 504
Nazione #
DE - Germania 112
HK - Hong Kong 106
US - Stati Uniti d'America 82
FI - Finlandia 51
IT - Italia 35
SG - Singapore 24
RU - Federazione Russa 23
BR - Brasile 22
VN - Vietnam 7
CN - Cina 6
AT - Austria 5
IN - India 5
KR - Corea 4
CA - Canada 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
GR - Grecia 2
IE - Irlanda 2
JP - Giappone 2
BY - Bielorussia 1
ES - Italia 1
KG - Kirghizistan 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
SE - Svezia 1
SN - Senegal 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 504
Città #
Munich 108
Hong Kong 106
Helsinki 38
Dallas 37
Chandler 10
Singapore 10
Princeton 7
Dong Ket 6
Jyväskylä 6
Turku 6
Fisciano 4
Milan 4
Naples 4
Nuremberg 4
Beijing 3
Belo Horizonte 3
Vienna 3
Andover 2
Ann Arbor 2
Boston 2
Brno 2
Dublin 2
Jacksonville 2
Moscow 2
Mumbai 2
New York 2
Pátrai 2
Salerno 2
Seattle 2
Seoul 2
São Paulo 2
Wilmington 2
Amsterdam 1
Araraquara 1
Arezzo 1
Ashburn 1
Bagno A Ripoli 1
Betim 1
Bishkek 1
Boardman 1
Cachoeirinha 1
Camaçari 1
Cambé 1
Canoas 1
Caserta 1
Cava de' Tirreni 1
Changsha 1
Concord 1
Dakar 1
Fairfield 1
Governador Valadares 1
Haiphong 1
Homyel 1
Imperatriz 1
Indaiatuba 1
Izmir 1
Karachi 1
London 1
Madrid 1
Paulo Afonso 1
Phoenix 1
Ponta Grossa 1
Ponta Porã 1
Pune 1
Ribeirão Preto 1
Sabará 1
Sarno 1
Secaucus 1
Sorocaba 1
São Sebastião do Paraíso 1
Tashkent 1
Tijucas 1
Vilnius 1
Volgograd 1
Totale 431
Nome #
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 260
rs822336 as a predictive biomarker for anti-PD-1/PD-L1 immunotherapy in advanced NSCLC: Unraveling molecular mechanisms 137
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 52
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 42
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies 23
Association between opioid use and survival in advanced non small cell lung cancer patients treated with immune checkpoint inhibitors 2
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanoma 1
Totale 517
Categoria #
all - tutte 1.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 10 1 0 1 0 6
2021/202214 0 0 0 0 1 2 1 2 2 1 0 5
2022/202321 2 2 0 2 3 5 0 1 4 1 1 0
2023/202415 2 0 0 0 0 2 5 1 1 1 0 3
2024/2025269 5 1 2 5 2 43 81 35 47 9 16 23
2025/2026166 20 105 34 7 0 0 0 0 0 0 0 0
Totale 517